You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The researchers explained why the virus was given the SARS-CoV-2 name and why it is not considered a new species.
The two organizations are collaborating to perform a standardized evaluation of currently available molecular diagnostic tests to assess test performance.
Mere weeks after the 2019-nCoV sequence was released, firms, agencies, and research groups have already created PCR-based tests.
The Los Angeles Times reports that a case of the novel coronavirus making people ill in China has been reported in the US.
Sequencing analysis has tied a new coronavirus to the pneumonia outbreak occurring in China, Vox reports.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
The NAM, NAS, and Royal Society have formed a commission to develop a framework on the proper use of genome editing, and convened its first meeting in Washington, DC, this week.
The World Health Organization says it accepts its panel's finding that moving forward with clinical applications of germline genome editing would be irresponsible.
The World Health Organization has updated its list of essential medicines, Reuters reports.
The commission will develop a framework for scientists, clinicians, and regulatory authorities on the appropriate use of human germline genome editing.
A German shepherd called Nala has had her genome sequenced.
A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?
Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.
In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.